Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07692217 · ClinicalTrials.gov registry record
TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Not yet
- Registry status
- 60
- Enrollment target
NCT07692217 is a clinical trial that has not yet begun recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants.
The verdict
NCT07692217 has not yet begun recruiting, sponsored by University of Texas Southwestern Medical Center.
- NOT YET RECRUITING
- Registry status
- 60 participants
- Enrollment target
Study Summary
This is an observational research study to find out if there is a difference in the way children with moderate or severe hemophilia A, treated on two different types of factor replacement, form a clot and also evaluate if they develop tiny bleeds within the joint and subsequently early joint changes when receiving extended half-life factor VIII.
Interventions
- DRUG Half-life factor VIII based replacement therapy
- DRUG Non-FVIII based replacement therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-07 |
| Est. Completion | 2033-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07692217
The ClinicalTrials.gov registry entry for NCT07692217 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Half-life factor VIII based replacement therapy is the first listed.
NCT07692217 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07692217 about?
NCT07692217 is a clinical study titled "TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies". This is an observational research study to find out if there is a difference in the way children with moderate or severe hemophilia A, treated on two different types of factor replacement, form a clot and also evaluate if they develop tiny bleeds within the joint and subsequently early joint changes...
What is the current status of trial NCT07692217?
This trial is currently not yet recruiting. The enrollment target is 60 participants. The study started on 2026-07. Estimated completion is 2033-05.
What interventions are being tested in trial NCT07692217?
The interventions under investigation include: Half-life factor VIII based replacement therapy (DRUG), Non-FVIII based replacement therapy (DRUG).
Who is sponsoring clinical trial NCT07692217?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.